Exeliom Biosciences
Mathilde Delaunay has worked in various roles in the past six years. In 2014, they were a General Secretary and Administrator and Project Manager for HEC Junior Conseil. In 2015, they were a Junior Consultant Intern for KAIRN Strategy Consulting. In 2016, they were an Entrepreneur in Residence at the Imagine Institute of Genetic Diseases and Right-hand of the Founders - Product Development & Customer Success at teambay. In 2017, they were a Project Manager and Jeune Entrepreneur en Résidence at Agoranov. In 2018, they were an Operations Director, Senior Operations Manager, and Operations Manager at Exeliom Biosciences. Additionally, in 2018 they were Right-hand of the Founder at Nextmind.
Mathilde Delaunay has a diverse educational background. Mathilde attended Lycée Saint Paul - Lille from 2008 to 2011, graduating with a Baccalauréat Mention Très Bien. Mathilde then attended Lycée Sainte Geneviève from 2011 to 2013, completing a Classe préparatoire aux grandes écoles. From 2013 to 2017, they attended HEC Paris, without completing a degree. In 2015, they attended CUHK Business School for a Summer Program. Finally, from 2016 to 2017, they attended Université Paris Cité, where they completed their Master BioMedical Engineering (BME) in Biologie, général.
This person is not in any teams
Exeliom Biosciences
Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.